Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of adverse effects of salmeterol in asthma
2019-003036-23Phase 4Unknown
- Sponsor
- Imperial College London
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of salmeterol and salmeterol + fluticasone in asthma, sponsored by Imperial College London. Primary endpoint: Change from baseline in airway pro-inflammatory mediator expression after salmeterol monotherapy. Status: unknown.
02
Drugs
salmeterolsalmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2019-003036-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003036-23.